Literature DB >> 17981590

Biomimetic material systems for neural progenitor cell-based therapy.

Wyatt Potter1, Ronald E Kalil, Weiyuan J Kao.   

Abstract

Reconstruction and regeneration of the central nervous system (CNS) following injury is a formidable task. However, cell replacement with transplanted neural progenitor cells (NPC) is a promising technique that has resulted in various levels of functional recovery in animals that had experienced an experimental injury of the brain or spinal cord. Unfortunately, CNS injury often leads to significant tissue damage and loss, limiting the survival and integration of transplanted NPC. In response, researchers have developed many biomaterial substrates that have been used to culture, transplant, and influence the differentiation and integration of transplanted NPC. Biomaterial scaffolds are a three-dimensional lattice that can be engineered to support NPC in vitro as well as serving as a temporary extracellular matrix (ECM) after transplantation. Scaffold modification with bioactive components, such as proteins, adhesive peptide sequences, and growth factors, allow researchers to modulate NPC responses as well as the local environment of the transplantation site. Biomimetic approaches also can include materials that recapitulate the structural dimensions of the ECM, namely self-assembling nanofibers. These materials can be useful for altering the tissue microenvironment by reducing inflammation and glial scarring, which may further enhance NPC survival and integration into functional neural circuitry. This review describes various biomaterial constructs, with a focus on biomimetic systems that have been used in modulating NPC behavior in culture and/or in transplanting NPC to the CNS.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17981590     DOI: 10.2741/2721

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  28 in total

1.  Improving the cell distribution in collagen-coated poly-caprolactone knittings.

Authors:  Weilun Sun; Dorien M Tiemessen; Marije Sloff; Rianne J Lammers; Eric L W de Mulder; Jöns Hilborn; Bhuvanesh Gupta; Wout F J Feitz; Willeke F Daamen; Toin H van Kuppevelt; Paul J Geutjes; Egbert Oosterwijk
Journal:  Tissue Eng Part C Methods       Date:  2012-05-10       Impact factor: 3.056

Review 2.  Hydrogels in spinal cord injury repair strategies.

Authors:  Giuseppe Perale; Filippo Rossi; Erik Sundstrom; Sara Bacchiega; Maurizio Masi; Gianluigi Forloni; Pietro Veglianese
Journal:  ACS Chem Neurosci       Date:  2011-05-04       Impact factor: 4.418

Review 3.  Mesenchymal stem cells engineered for cancer therapy.

Authors:  Khalid Shah
Journal:  Adv Drug Deliv Rev       Date:  2011-06-29       Impact factor: 15.470

4.  Effects of biologic scaffolds on human stem cells and implications for CNS tissue engineering.

Authors:  Peter M Crapo; Stephen Tottey; Peter F Slivka; Stephen F Badylak
Journal:  Tissue Eng Part A       Date:  2013-10-10       Impact factor: 3.845

5.  Encapsulated therapeutic stem cells implanted in the tumor resection cavity induce cell death in gliomas.

Authors:  Timo M Kauer; Jose-Luiz Figueiredo; Shawn Hingtgen; Khalid Shah
Journal:  Nat Neurosci       Date:  2011-12-25       Impact factor: 24.884

6.  D-RADA16-RGD-Reinforced Nano-Hydroxyapatite/Polyamide 66 Ternary Biomaterial for Bone Formation.

Authors:  WeiKang Zhao; Bin He; Ao Zhou; Yuling Li; Xiaojun Chen; Qiming Yang; Beike Chen; Bo Qiao; Dianming Jiang
Journal:  Tissue Eng Regen Med       Date:  2019-01-05       Impact factor: 4.169

7.  Encapsulated stem cells loaded with hyaluronidase-expressing oncolytic virus for brain tumor therapy.

Authors:  Jordi Martinez-Quintanilla; Derek He; Hiroaki Wakimoto; Ramon Alemany; Khalid Shah
Journal:  Mol Ther       Date:  2014-10-29       Impact factor: 11.454

8.  Localized cell and drug delivery for auditory prostheses.

Authors:  Jeffrey L Hendricks; Jennifer A Chikar; Mark A Crumling; Yehoash Raphael; David C Martin
Journal:  Hear Res       Date:  2008-06-07       Impact factor: 3.208

9.  Transplantation of human neural precursor cells in Matrigel scaffolding improves outcome from focal cerebral ischemia after delayed postischemic treatment in rats.

Authors:  Kunlin Jin; Xiaoou Mao; Lin Xie; Veronica Galvan; Bin Lai; Yaoming Wang; Olivia Gorostiza; Xiaomei Wang; David A Greenberg
Journal:  J Cereb Blood Flow Metab       Date:  2009-10-14       Impact factor: 6.200

10.  Delayed transplantation of human marrow stromal cell-seeded scaffolds increases transcallosal neural fiber length, angiogenesis, and hippocampal neuronal survival and improves functional outcome after traumatic brain injury in rats.

Authors:  Ye Xiong; Changsheng Qu; Asim Mahmood; Zhongwu Liu; Ruizhuo Ning; Yi Li; David L Kaplan; Timothy Schallert; Michael Chopp
Journal:  Brain Res       Date:  2009-01-30       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.